Edward Tung, legal counsel at ORI Capital/Courtesy photo Edward Tung is legal counsel, head of compliance and chair of the risk management committee for ORI Capital, a Hong Kong-based venture capital firm launched in 2015 that focuses on investing in innovative healthcare companies globally. ORI Healthcare Fund has a fund size of $200 million, while ORI Healthcare Fund II has a target fund size of $400 million. Prior to joining the firm in 2019, Tung was an associate at the Hong Kong-based international law firm Deacons. We asked him about the growing importance of ESG, the rise of special purpose acquisition companies (SPACs) in the United States and his decision to switch from working in science to working in the law.
This Q&A has been lightly edited for clarity and brevity.
You are one of very few lawyers who has a Ph.D. in microbiology. What made you decide to pursue a
A Subscription is Required to Access this Content
Subscribe to China Law & Practice today for:
- ✓ A database of 3000+ essential documents, including key PRC laws translated into English
- ✓ Newsletters with business-critical and sector-specific updates
- ✓ Premium mobile access with timely analysis on China's fast-changing market
Already a Subscriber? Log In. Sign In Now
Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)